Interleukin-6 (IL-6), derived from cancer-associated fibroblasts (CAFs), plays a crucial role in initiating the activation of the STAT3 pathway in tumor-infiltrating neutrophils, known as TANs. This evidence concerns the gene IL6 and cancer.